These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16740689)

  • 21. Over-expression of topoisomerase IIalpha is related to the grade of cervical intraepithelial neoplasia (CIN) and high-risk human papillomavirus (HPV), but does not predict prognosis in cervical cancer or HPV clearance after cone treatment.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen SM; Favalli C; Syrjänen K;
    Int J Gynecol Pathol; 2006 Oct; 25(4):383-92. PubMed ID: 16990717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
    Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
    Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.
    Lee S; Kim JH; Kim H; Kang JW; Kim SH; Yang Y; Kim J; Park J; Park S; Hong J; Yoon DY
    Immunology; 2011 Mar; 132(3):410-20. PubMed ID: 21208204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
    Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
    Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer.
    Amortegui AJ; Meyer MP; Elborne VL; Amin RM
    Mod Pathol; 1995 Dec; 8(9):907-12. PubMed ID: 8751330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.
    Scarpini CG; Groves IJ; Pett MR; Ward D; Coleman N
    J Pathol; 2014 Jul; 233(3):281-93. PubMed ID: 24752734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of basal cell fate during productive and transforming HPV-16 infection is mediated by progressive E6-driven depletion of Notch.
    Kranjec C; Holleywood C; Libert D; Griffin H; Mahmood R; Isaacson E; Doorbar J
    J Pathol; 2017 Aug; 242(4):448-462. PubMed ID: 28497579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
    Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
    Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-135a leads to cervical cancer cell transformation through regulation of β-catenin via a SIAH1-dependent ubiquitin proteosomal pathway.
    Leung CO; Deng W; Ye TM; Ngan HY; Tsao SW; Cheung AN; Pang RT; Yeung WS
    Carcinogenesis; 2014 Sep; 35(9):1931-40. PubMed ID: 24503442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia.
    Ajiro M; Sakai H; Onogi H; Yamamoto M; Sumi E; Sawada T; Nomura T; Kabashima K; Hosoya T; Hagiwara M
    Clin Cancer Res; 2018 Sep; 24(18):4518-4528. PubMed ID: 29712686
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha.
    Boccardo E; Manzini Baldi CV; Carvalho AF; Rabachini T; Torres C; Barreta LA; Brentani H; Villa LL
    Carcinogenesis; 2010 Mar; 31(3):521-31. PubMed ID: 20042637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions.
    Paolini F; Curzio G; Melucci E; Terrenato I; Antoniani B; Carosi M; Mottolese M; Vici P; Mariani L; Venuti A
    Eur J Cancer; 2016 May; 58():52-61. PubMed ID: 26963794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
    Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
    Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
    Yablonska S; Hoskins EE; Wells SI; Khan SA
    Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle.
    Morgan EL; Wasson CW; Hanson L; Kealy D; Pentland I; McGuire V; Scarpini C; Coleman N; Arthur JSC; Parish JL; Roberts S; Macdonald A
    PLoS Pathog; 2018 Apr; 14(4):e1006975. PubMed ID: 29630659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
    Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
    Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells.
    Allison SJ; Jiang M; Milner J
    Aging (Albany NY); 2009 Mar; 1(3):316-27. PubMed ID: 20157519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.
    Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
    Eur J Gynaecol Oncol; 2006; 27(3):215-23. PubMed ID: 16800245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
    Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
    Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle regulators p105, p107, Rb2/p130, E2F4, p21CIP1/WAF1, cyclin A in predicting cervical intraepithelial neoplasia, high-risk human papillomavirus infections and their outcome in women screened in three new independent states of the former Soviet Union.
    Santopietro R; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Tosi P; Syrjänen K; Syrjänen S
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1250-6. PubMed ID: 16835319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.